Serum procalcitonin was determined in newborn infants at the time of admission to the pediatrics or obstetrics unit. Neonatal sepsis is classified as early or late according to the age of onset during the neonatal period 2. Objective to investigate the accuracy of procalcitonin pct as a diagnostic marker of nosocomial sepsis ns and define the most accurate cutoff to distinguish infected from uninfected neonates. The evaluation of serum procalcitonin levels in neonatal infections. To compare between creactive protein crp and procalcitonin pct regarding diagnosis and outcome of neonatal sepsis. Cord blood procalcitonin in the assessment of earlyonset.
To investigate the reliability of serum procalcitonin pct as an early diagnostic test within the first 12 hours of life of neonatal sepsis in newborns with maternal or. Neonatal procalcitonin intervention study full text view. The results so far are very encouraging and may suggest that in the near future the pct may be used routinely for diagnosis of neonatal sepsis and can provide a lifesaving approach for newborns. Procalcitonin pct, a prohormone of calcitonin has been described as a specific. What is already known on this topic early diagnosis of neonatal sepsis remains a relevant problem in neonatal intensive care units. Current clinical laboratory methods in the diagnosis of bacterial infections are either nonspecific or require longer turnaround times. Procalcitonin assisted antibiotic strategy in sepsis these efforts clearly show that finding the appropriate definition of sepsis has been a continuous challenge for more than 30 years. Procalcitonin guided decision making was superior to standard care in reducing antibiotic therapy in neonates with suspected earlyonset sepsis. The diagnosis of sepsis in critically ill patients is challenging because traditional markers of infection are often misleading.
Pneumonia is the most common cause of sepsis in the united. In this regard, currently procalcitonin has been known to play a major role for early diagnosis of neonatal sepsis 8, 9. Cord blood acute phase reactants predict early onset neonatal sepsis in preterm infants. In these studies, pct sensitivity in the early diagnosis of neonatal sepsis was found to be 83100% while the specificity was 70100% 9, 12, 18. Pct can contribute to the risk assessment and optimization of patient management and clinical decisions. Procalcitoninguided decision making for duration of. Procalcitonin and creactive protein crp levels were measured within 3 days of sepsis w up events. Accuracy of serum procalcitonin for the diagnosis of sepsis in neonates and children with systemic inflammatory syndrome.
It is becoming a frequent complication in hospitalized patients. We read with interest the article by christina wacker and colleagues1 about the use of procalcitonin as a sepsis biomarker. Contrary to a previous metaanalysis,2 the investigators conclude that procalcitonin usefully differentiates sepsis from a systemic inflammatory response syndrome sirs arising from noninfectious causes. Globally, sepsis and its complications are a major cause of acute illness and death.
Confident diagnosis of neonatal sepsis with procalcitonin pct from the first day of life. Procalcitonin pct is a peptide precursor of the hormone calcitonin, the latter being involved with calcium homeostasis. Neonatal sepsis is a leading cause of global mortality in children younger than 5 years ref4. Procalcitonin pct was demonstrated to be an accurate biomarker for the diagnosis of sepsis in adults and showed to be promising in paediatrics. Sepsis is a global healthcare problem, characterized by whole body inflammation in response to microbial infection, which leads to organ dysfunction. Usefulness of procalcitonin for diagnosis of sepsis in the. Although improvements in neonates care have increased survival, sepsis is still one of. But some investigators questioned the diagnostic accuracy of pct in detecting of. Procalcitonin for the diagnosis of neonatal sepsis of vertical transmission. Patients 762 neonates admitted to six nicus during a 28month observational study for whom at least one serum sample was taken on admission. The difficulty in defining sepsis originates from its complex pathophysiology, which is affected by numerous individual variations of the host response. However, these tests lack high specificity in diagnosing neonatal sepsis 7. Reference values for pct in sepsis patients the absolute level of pct concentrations increase with increasing severity of disease.
Because the diagnostic accuracy of procalcitonin is only moderate, we do not routinely use procalcitonin to aid patients with septicemia caused by other organisms. This study investigated the value of pct in the diagnosis of neonatal sepsis. The burden of neonatal sepsis remains unchanged over the past decade at about 12 live births for early onset sepsis eos and 6. Early and differential diagnosis of sepsis is needed critically to avoid unnecessary usage of antimicrobial agents and for proper antibiotic treatments through the screening. Procalcitonin pct in cord blood could provide a diagnosis. Accurate and quick diagnosis are difficult because. Procalcitonin use to predict bacterial infection in. To determine the diagnostic accuracy of serum procalcitonin levels pct by taking blood culture as gold standard.
In common clinical usage, neonatal sepsis refers to a bacterial blood stream infection in the first month of life, such as meningitis, pneumonia, pyelonephritis, or gastroenteritis, but neonatal sepsis also may be due to infection with fungi, viruses, or parasites. Early diagnosis of earlyonset neonatal sepsis eons is essential to reduce morbidity and mortality. Lancet 2017 jul 12 use of procalcitonin measurements was associated with shorter antibiotic courses for suspected earlyonset neonatal sepsis. Biomarkers for diagnosis of sepsis in patients with systemic inflammatory response syndrome.
The gold standard for the diagnosis of neonatal sepsis is a positive culture in the blood, urine, cerebrospinal fluid, peritoneal fluid, or any other sterile tissues, 14. In several studies procalcitonin was found to be the best available marker for sepsis diagnosis in neonates ref1, 2, 3. In highincome countries hic, early onset neonatal sepsis eons is defined as appearing in the first 72 hours after birth, as opposed to late onset neonatal sepsis lons, onset more than or equal to 72 hours after birth. Procalcitonin assisted antibiotic strategy in sepsis. Procalcitoninguided decision making to shorten antibiotic. Why should procalcitonin testing be a part of the sepsis management protocol. Fast procalcitonin pct assay has been investigated as a marker of infection. Procalcitonin in detecting neonatal nosocomial sepsis. Although several studies that used a sensitive assay were included. Serum procalcitonin levels distinguish gramnegative bacterial sepsis from gram.
Neonates with viral infection, bacterial colonization, or neonatal distress had normal or slightly increased levels. The american college of chest physicians and society of critical care medicine defined sepsis as. In lmic settings, many neonates are born outside of healthcare facilities, and might. Neonatal sepsis can also be defined as clinically diagnosed or confirmed by positive culture in a typically sterile bodily fluid.
An expert meeting on neonatal and paediatric sepsis was organised on 8 june 2010 at the ema in an effort to address a number of issues with regard to conducting clinical trials in neonatal and paediatric severe sepsis. Procalcitonin was positive in 100% compared to the crp positivity in 63. Procalcitoninguided decision making was superior to standard care in reducing antibiotic therapy in neonates with suspected earlyonset sepsis. Procalcitonin pct is a biomarker that exhibits greater specificity than other proinflammatory markers eg, cytokines in identifying patients with sepsis and can be used in the diagnosis of bacterial infections. The present study was conducted to determine the procalcitonin level at early diagnosis and differentiation in patients with systemic inflammatory response syndrome sirs and sepsis, in comparison with creactive protein, il2, il6, il8 and tumour necrosis. Neonatal sepsis is a major cause of mortality in developing countries. To document the relationships between procalcitonin pct, creactive protein crp and leucocyte count wcc in children with sepsis, and to compare their diagnostic value in septic shock. Proven earlyonset sepsis has mortality rates as high as 30% in highincome countries. Procalcitonin is a serum biomarker that rises in response to bacterial infections. Blood samples were drawn from 36 infants during 85 episodes of sepsis performed between 4 and 66 of life. Report on the expert meeting on neonatal and paediatric. Procalcitonin pct was demonstrated to be an accurate biomarker for the. Research article open access procalcitonin versus c. Pdf procalcitonin as a diagnostic marker of sepsis in.
Neonatal bacterial sepsis is a major cause of mortality and morbidity and early antibiotic therapy is crucial for treatment success. Is procalcitonin useful in pediatric critical care patients. Does it have a role in screening for earlyonset neonatal sepsis. In a recent study koksal et al concluded that serum procalcitonin level was superior to serum crp level in terms of early diagnosis of neonatal sepsis, in detecting the severity of the illness and in evaluation of the response to.
Serum procalcitonin pct has been proposed as an early marker of infections in neonates. Background procalcitonin versus creactive protein in neonatal sepsis ali am1, elkhatib wf2,3 and abdelaziz ss4. Procalcitonin as a marker for the early diagnosis of. Early diagnosis of neonatal sepsis and appropriate treatment decreases the mortality and morbidity of these infants. Crp and procalcitonin pct are widely used and have perhaps been most. Procalcitonin pct in cord blood could provide a diagnosis of infected patients from birth.
Is procalcitonin pct a suitable marker for monitoring, diagnosing, or predicting outcomes for sepsis. Noninferiority for reinfection or death could not be shown due to the low occurrence of reinfections and absence of studyrelated death. Antigen was detected in 88 of 107 pneumococcal bacteremic patients 82 percent compared with 3 of 106 patients with bacteremia due to other. In several studies procalcitonin was found to be the best available marker for sepsis diagnosis in neonates ref1, 2, 3 neonatal sepsis is a leading cause of global mortality in children younger than 5 years ref4. Neonatal sepsis is one of the leading causes of death as reported by the world health organization for the years 2005 and 2010, even when the development and understanding of diagnostic and prognostic markers such as procalcitonin have facilitated early diagnosis, management and proper prognosis in recent years. Pdf diagnostic value of procalcitonin in neonatal sepsis. However, as an expression of individually different immune responses and different clinical situations, the same focus of infection may be associated with varying individual elevations in pct concentrations.
Pdf procalcitonin as a marker of neonatal sepsis researchgate. Serum procalcitonin as a diagnostic marker for neonatal sepsis. Definition neonatal septicemia is defined as generalized systemic features of infection,associated with pure growth of bacteria from one or more sites,in a newborn. Indian journal of critical care medicine, year 2011 janmarch, volume 15, issue 1 p. It arises once preprocalcitonin is cleaved by endopeptidase. A reliable marker for the diagnosis of neonatal sepsis.
This was a crosssectional study conducted in neonatal. Implications of procalcitonin as a prognostic marker in. Blood samples were collected at admission from 69 neonates with suspected infection admitted to the neonatal intensive care units at alzahra and dr beheshti. Neonatal sepsis is a diagnosis made in infants less than 28 days of life and consists of a clinical syndrome that may include systemic signs of infection, circulatory shock, and multisystem organ failure. Procalcitonin in paediatric sepsis critical care full text. Seventy newborn infants admitted to nicu for sepsis management. The investigators hypothesize that procalcitonin pct has a reliable negative predictive values to allow a reduction in duration of empiric antibiotic therapy in suspected neonatal earlyonset sepsis with unchanged outcome. Pct has gained evidential support as a biomarker for diagnosing bacterial sepsis and guiding.
A number of biomarkers have been studied for the diagnosis of sepsis in paediatrics, but no gold standard has been identified. Antibiotic use for sepsis in neonates and children. Sepsis, sepsis neonatal, procalcitonina, marcadores, sensibilidad, especificidad. Determination of the procalcitonin levels for the diagnosis of neonatal sepsis. A novel biomarker called procalcitonin pct is now being recognized as a useful tool in the diagnostic process for sepsis. This study is designed as a multicenter, prospective, randomized intervention trial. Many authors found that procalcitonin is a promising marker for the diagnosis of neonatal sepsis 10, 12, 18. These guidelines recommend early determination of serum procalcitonin concentrations to rule out severe sepsis andor confirm the diagnosis, and state that serial procalcitonin measurements may be considered in order to shorten the duration of antimicrobial therapy. Accuracy of serum procalcitonin for the diagnosis of sepsis in. Sepsis,biomarker, procalcitonin pct, neonatal sepsis. To evaluate the effect of procalcitoninguided decision making on duration opf antibiotic therapy in suspected neonatal earlyonset sepsis.
1192 489 361 418 676 557 970 392 1441 1031 814 1217 1057 630 1052 579 76 361 1148 467 631 452 604 893 768 1430 1075 17 1349 605 694 1270 871 642 1489 787 399 468 775 4 68 791 1393